000			02202 a2200553 4500
005			20250515164807.0
264		0	_c20090615
008			200906s 0 0 eng d
022			_a1549-490X
024	7		_a10.1634/theoncologist.2008-0261 _2doi
040			_aNLM _beng _cNLM
100	1		_aMorabito, Alessandro
245	0	0	_aVandetanib (ZD6474), a dual inhibitor of vascular endothelial growth factor receptor (VEGFR) and epidermal growth factor receptor (EGFR) tyrosine kinases: current status and future directions. _h[electronic resource]
260			_bThe oncologist _cApr 2009
300			_a378-90 p. _bdigital
500			_aPublication Type: Journal Article; Review
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects
650	0	4	_aCarcinoma, Non-Small-Cell Lung _xdrug therapy
650	0	4	_aClinical Trials, Phase I as Topic
650	0	4	_aClinical Trials, Phase II as Topic
650	0	4	_aClinical Trials, Phase III as Topic
650	0	4	_aDocetaxel
650	0	4	_aDrug Therapy _xmethods
650	0	4	_aErbB Receptors _xdrug effects
650	0	4	_aGlutamates _xadministration & dosage
650	0	4	_aGuanine _xadministration & dosage
650	0	4	_aHumans
650	0	4	_aLung Neoplasms _xdrug therapy
650	0	4	_aPemetrexed
650	0	4	_aPiperidines _xadministration & dosage
650	0	4	_aQuinazolines _xadministration & dosage
650	0	4	_aRandomized Controlled Trials as Topic
650	0	4	_aReceptors, Vascular Endothelial Growth Factor _xdrug effects
650	0	4	_aSmall Cell Lung Carcinoma _xdrug therapy
650	0	4	_aTaxoids _xadministration & dosage
650	0	4	_aTreatment Outcome
650	0	4	_aVascular Endothelial Growth Factor Receptor-1 _xdrug effects
700	1		_aPiccirillo, Maria Carmela
700	1		_aFalasconi, Fabiano
700	1		_aDe Feo, Gianfranco
700	1		_aDel Giudice, Antonia
700	1		_aBryce, Jane
700	1		_aDi Maio, Massimo
700	1		_aDe Maio, Ermelinda
700	1		_aNormanno, Nicola
700	1		_aPerrone, Francesco
773	0		_tThe oncologist _gvol. 14 _gno. 4 _gp. 378-90
856	4	0	_uhttps://doi.org/10.1634/theoncologist.2008-0261 _zAvailable from publisher's website
999			_c18784343 _d18784343